| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2016 | Stafford John S III | 10% Owner | Sell | 63,061 | $27.71 | $1,747,105.01 | -1.2% | |
| Dec 5, 2016 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sale+OE | 45,000 | $26.57 | $1,195,515.00 | -30.7% | |
| Sep 28, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 10,000 | $25.35 | $253,474.89 | -77.2% | |
| Sep 27, 2016 | Stafford John S III | 10% Owner | Sell | 40,000 | $25.72 | $1,028,813.38 | -0.3% | |
| Sep 2, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 10,000 | $21.06 | $210,641.00 | -100% | |
| Aug 30, 2016 | Dahiyat Bassil I74 | President And CEO | Sell | 40,000 | $21.80 | $872,028.00 | -10.5% | |
| Aug 26, 2016 | Stafford John S III | 10% Owner | Sell | 24,351 | $21.48 | $523,059.48 | -0.5% | |
| Aug 24, 2016 | Kuch John J68 | Vice President, Finance | Sale+OE | 25,000 | $21.95 | $548,813.20 | -14.9% | |
| Aug 23, 2016 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sell | 16,294 | $21.73 | $354,065.36 | -36.3% | |
| Aug 23, 2016 | Stafford John S III | 10% Owner | Sell | 96,828 | $21.73 | $2,103,632.46 | -0.9% |